Viewing Study NCT01259102


Ignite Creation Date: 2025-12-25 @ 3:53 AM
Ignite Modification Date: 2026-01-29 @ 3:59 AM
Study NCT ID: NCT01259102
Status: COMPLETED
Last Update Posted: 2012-09-03
First Post: 2010-12-10
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Examine Plasma Concentrations of Buprenorphine Following Reapplication of Buprenorphine Transdermal System (BTDS) After Variable Application Site Rest Periods
Sponsor: Purdue Pharma LP
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Healthy subjects View
None Opioid View
None Transdermal View